Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Education and training of clinical and translational study investigators and research coordinators: A competency-based approach.

Calvin-Naylor NA, Jones CT, Wartak MM, Blackwell K, Davis JM, Divecha R, Ellerbeck EF, Kieburtz K, Koziel MJ, Luzuriaga K, Maddox J, Needler NA, Murphy S, Pemberton K, Radovich C, Rubinstein EP, Selker HP, Tenaerts P, Unsworth K, Wilson K, Wright JE, Barohn R, Shanley TP.

J Clin Transl Sci. 2017 Feb;1(1):16-25. doi: 10.1017/cts.2016.2. Epub 2017 Jan 13.

2.

VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection.

Di Bisceglie AM, Sulkowski M, Gane E, Jacobson IM, Nelson D, DeSouza C, Alves K, George S, Kieffer T, Zhang EZ, Kauffman R, Asmal M, Koziel MJ.

Eur J Gastroenterol Hepatol. 2014 Jul;26(7):761-73. doi: 10.1097/MEG.0000000000000084.

PMID:
24901821
3.

Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C.

Yanagisawa K, Yue S, van der Vliet HJ, Wang R, Alatrakchi N, Golden-Mason L, Schuppan D, Koziel MJ, Rosen HR, Exley MA.

J Viral Hepat. 2013 Aug;20(8):556-65. doi: 10.1111/jvh.12081. Epub 2013 Mar 11.

4.

Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis.

Li S, Vriend LE, Nasser IA, Popov Y, Afdhal NH, Koziel MJ, Schuppan D, Exley MA, Alatrakchi N.

Hepatology. 2012 Dec;56(6):2094-105. doi: 10.1002/hep.25951.

5.

Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C.

Morishima C, Di Bisceglie AM, Rothman AL, Bonkovsky HL, Lindsay KL, Lee WM, Koziel MJ, Fontana RJ, Kim HY, Wright EC; HALT-C Trial Group.

J Viral Hepat. 2012 Jun;19(6):404-13. doi: 10.1111/j.1365-2893.2011.01562.x. Epub 2011 Dec 16.

6.

Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.

Anthony DD, Umbleja T, Aberg JA, Kang M, Medvik K, Lederman MM, Peters MG, Koziel MJ, Overton ET.

Vaccine. 2011 Apr 27;29(19):3558-63. doi: 10.1016/j.vaccine.2011.02.092. Epub 2011 Mar 11.

7.

Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection.

Garg S, Hoenig M, Edwards EM, Bliss C, Heeren T, Tumilty S, Walley AY, Koziel MJ, Skolnik PR, Horsburgh CR, Cotton D.

AIDS Patient Care STDS. 2011 Mar;25(3):135-41. doi: 10.1089/apc.2010.0104. Epub 2011 Feb 10.

8.

Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).

Sherman KE, Andersen JW, Butt AA, Umbleja T, Alston B, Koziel MJ, Peters MG, Sulkowski M, Goodman ZD, Chung RT; AIDS Clinical Trials Group A5178 Study Team.

J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):597-605. doi: 10.1097/QAI.0b013e3181f6d916.

9.

Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.

Overton ET, Kang M, Peters MG, Umbleja T, Alston-Smith BL, Bastow B, Demarco-Shaw D, Koziel MJ, Mong-Kryspin L, Sprenger HL, Yu JY, Aberg JA.

Vaccine. 2010 Aug 2;28(34):5597-604. doi: 10.1016/j.vaccine.2010.06.030. Epub 2010 Jun 23.

10.

Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection.

Nunes D, Fleming C, Offner G, Craven D, Fix O, Heeren T, Koziel MJ, Graham C, Tumilty S, Skolnik P, Stuver S, Horsburgh CR Jr, Cotton D.

Am J Gastroenterol. 2010 Jun;105(6):1346-53. doi: 10.1038/ajg.2009.746. Epub 2010 Feb 23.

PMID:
20179698
11.

Translational research in liver disease.

Koziel MJ.

Hepatology. 2008 Oct;48(4):1028-9. doi: 10.1002/hep.22528. No abstract available.

PMID:
18821590
12.

Immune responses during acute and chronic infection with hepatitis C virus.

Ishii S, Koziel MJ.

Clin Immunol. 2008 Aug;128(2):133-47. doi: 10.1016/j.clim.2008.03.525. Epub 2008 Jun 2. Review.

13.

Resolution of chronic hepatitis C following parasitosis.

Byrnes V, Chopra S, Koziel MJ.

World J Gastroenterol. 2007 Aug 21;13(31):4268-9.

14.

HIV and liver disease forum: conference proceedings.

Sherman KE, Peters M, Koziel MJ.

Hepatology. 2007 Jun;45(6):1566-77. No abstract available.

15.

Viral factors associated with cytokine expression during HCV/HIV co-infection.

Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters MG, Andersen J, Chung RT; Aids Clinical Trials Group A5071 Study Team.

J Interferon Cytokine Res. 2007 Apr;27(4):263-9.

16.

Viral hepatitis in HIV infection.

Koziel MJ, Peters MG.

N Engl J Med. 2007 Apr 5;356(14):1445-54. Review. No abstract available.

17.

Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses.

Alatrakchi N, Graham CS, van der Vliet HJ, Sherman KE, Exley MA, Koziel MJ.

J Virol. 2007 Jun;81(11):5882-92. Epub 2007 Mar 21.

18.

Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection.

Graham CS, Wells A, Edwards EM, Herren T, Tumilty S, Stuver SO, Samet JH, Nunes D, Horsburgh CR Jr, Koziel MJ.

J Infect Dis. 2007 Mar 15;195(6):847-56. Epub 2007 Feb 2.

PMID:
17299715
19.

Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.

Blackard JT, Kang M, Sherman KE, Koziel MJ, Peters MG, Chung RT.

J Interferon Cytokine Res. 2006 Nov;26(11):834-8.

21.

Immunology of hepatitis C virus infection.

Huang L, Koziel MJ.

Curr Opin Gastroenterol. 2000 Nov;16(6):558-64.

PMID:
17031138
22.

Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis.

Kamal SM, Turner B, He Q, Rasenack J, Bianchi L, Al Tawil A, Nooman A, Massoud M, Koziel MJ, Afdhal NH.

Hepatology. 2006 Apr;43(4):771-9.

PMID:
16557547
23.

Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.

Kamal SM, Fouly AE, Kamel RR, Hockenjos B, Al Tawil A, Khalifa KE, He Q, Koziel MJ, El Naggar KM, Rasenack J, Afdhal NH.

Gastroenterology. 2006 Mar;130(3):632-8. Erratum in: Gastroenterology. 2006 Sep;131(3):979.

PMID:
16530503
24.

Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.

Morishima C, Polyak SJ, Ray R, Doherty MC, Di Bisceglie AM, Malet PF, Bonkovsky HL, Sullivan DG, Gretch DR, Rothman AL, Koziel MJ, Lindsay KL; Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group.

J Infect Dis. 2006 Apr 1;193(7):931-40. Epub 2006 Feb 22.

PMID:
16518754
25.

NK cells: natural born killers in the conflict between humans and HCV.

Koziel MJ.

Hepatology. 2006 Mar;43(3):395-7. No abstract available.

PMID:
16496351
26.

Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.

Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ; ACTG 5071 Study Team.

AIDS. 2006 Feb 14;20(3):345-51.

27.

Influence of HIV co-infection on hepatitis C immunopathogenesis.

Koziel MJ.

J Hepatol. 2006;44(1 Suppl):S14-8. Epub 2005 Nov 21. Review.

PMID:
16338026
28.
29.

Structural proteins of Hepatitis C virus induce interleukin 8 production and apoptosis in human endothelial cells.

Balasubramanian A, Munshi N, Koziel MJ, Hu Z, Liang TJ, Groopman JE, Ganju RK.

J Gen Virol. 2005 Dec;86(Pt 12):3291-301.

PMID:
16298974
30.

Cellular immune responses against hepatitis C virus.

Koziel MJ.

Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S25-31. Review.

PMID:
16265610
31.

Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis.

Miller MF, Haley C, Koziel MJ, Rowley CF.

Clin Infect Dis. 2005 Sep 1;41(5):713-20. Epub 2005 Jul 22.

PMID:
16080095
32.

Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection.

Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ; ACTG 5071 Study Team.

AIDS. 2005 May 20;19(8):767-73.

33.

Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C.

Rothman AL, Morishima C, Bonkovsky HL, Polyak SJ, Ray R, Di Bisceglie AM, Lindsay KL, Malet PF, Chang M, Gretch DR, Sullivan DG, Bhan AK, Wright EC, Koziel MJ; HALT-C Trial Group.

Hepatology. 2005 Mar;41(3):617-25.

PMID:
15726656
34.

CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection.

Alatrakchi N, Graham CS, He Q, Sherman KE, Koziel MJ.

J Infect Dis. 2005 Mar 1;191(5):702-9. Epub 2005 Jan 28.

PMID:
15688283
35.

Natural killer cells and hepatitis C: is losing inhibition the key to clearance?

Herman RB, Koziel MJ.

Clin Gastroenterol Hepatol. 2004 Dec;2(12):1061-3. Review. No abstract available.

PMID:
15625649
36.

Prediction of relapse following treatment for hepatitis C: is whole blood more than the sum of its parts?

Shire N, Koziel MJ.

Clin Infect Dis. 2004 Dec 15;39(12):1761-3. Epub 2004 Nov 19. No abstract available.

PMID:
15578396
37.

Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients.

Kamal SM, Amin A, Madwar M, Graham CS, He Q, Al Tawil A, Rasenack J, Nakano T, Robertson B, Ismail A, Koziel MJ.

J Virol. 2004 Nov;78(22):12252-8.

38.

To be or not to be NKT: natural killer T cells in the liver.

Exley MA, Koziel MJ.

Hepatology. 2004 Nov;40(5):1033-40. Review.

PMID:
15486982
39.

HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV.

Qin H, Shire NJ, Keenan ED, Rouster SD, Eyster ME, Goedert JJ, Koziel MJ, Sherman KE; Multicenter Hemophilia Cohort Study Group.

Blood. 2005 Jan 15;105(2):533-41. Epub 2004 Sep 16.

40.

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C; AIDS Clinical Trials Group A5071 Study Team.

N Engl J Med. 2004 Jul 29;351(5):451-9.

41.

Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.

Durante-Mangoni E, Wang R, Shaulov A, He Q, Nasser I, Afdhal N, Koziel MJ, Exley MA.

J Immunol. 2004 Aug 1;173(3):2159-66.

42.

Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.

Graham CS, Curry M, He Q, Afdhal N, Nunes D, Fleming C, Horsburgh R, Craven D, Sherman KE, Koziel MJ.

Hepatology. 2004 Jul;40(1):125-32.

PMID:
15239095
43.

Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics.

Kamal SM, Ismail A, Graham CS, He Q, Rasenack JW, Peters T, Tawil AA, Fehr JJ, Khalifa Kel S, Madwar MM, Koziel MJ.

Hepatology. 2004 Jun;39(6):1721-31.

PMID:
15185314
44.

Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.

Kamal SM, Graham CS, He Q, Bianchi L, Tawil AA, Rasenack JW, Khalifa KA, Massoud MM, Koziel MJ.

J Infect Dis. 2004 Apr 1;189(7):1140-50. Epub 2004 Mar 12.

PMID:
15031780
45.

Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection.

Fleming CA, Christiansen D, Nunes D, Heeren T, Thornton D, Horsburgh CR Jr, Koziel MJ, Graham C, Craven DE.

Clin Infect Dis. 2004 Feb 15;38(4):572-8. Epub 2004 Jan 26.

PMID:
14765352
46.

A tale of two viruses: hepatitis C in the age of HAART.

Alatrakchi N, Koziel MJ.

Lancet. 2003 Nov 22;362(9397):1687-8. No abstract available.

PMID:
14643113
47.

Antiviral T-cell responses and therapy in chronic hepatitis B.

Alatrakchi N, Koziel MJ.

J Hepatol. 2003 Oct;39(4):631-4. Review. No abstract available.

PMID:
12971976
48.

Hepatitis C and alcohol: fundamental and translational research directions.

Morgan TR, Brenner D, Everhart J, French SW, Fried MW, Gretch DR, Koziel MJ, McClain CJ, Peters MG, Weinman SA, Lucas DL.

Alcohol Clin Exp Res. 2003 Apr;27(4):726-31. Review.

PMID:
12711937
49.

First things first: balancing hepatitis C and human immunodeficiency virus.

Graham CS, Koziel MJ.

Clin Infect Dis. 2003 Feb 1;36(3):368-9. Epub 2003 Jan 14. No abstract available.

PMID:
12539080
50.

Immunopathogenesis of hepatitis C virus in the immunosuppressed host.

Einav S, Koziel MJ.

Transpl Infect Dis. 2002 Jun;4(2):85-92. Review.

PMID:
12220245

Supplemental Content

Loading ...
Support Center